New Study Examines Key Factors for Improving IIT Management
CHAPEL HILL, N.C., May. 19, 2020/PRNewswire/ -- The number of investigator-initiated trial (IIT) submissions in the healthcare industry has increased in recent years, marking them as a critical operational area for most biopharma manufacturers.
Successful companies must manage a series of challenges in this area, including: proper vetting of proposals, approvals for those that demonstrate scientific merit and align with corporate strategy, and effective utilization of resources to ensure costs do not outrun results.
“Best Practices in the Oversight and Management of Investigator Initiated Trials,” is a 65-page report that provides a detailed roadmap for improving IIT management at bio-pharmaceutical companies, capturing critical metrics and insights on IIT management team structure, staffing, budget and performance metrics.
According to this research, types of IITs supported most often:
- Retrospective studies (96% of organizations support this type of IIT)
- Intervention studies (89% of organizations support this type of IIT)
- Gathering data about a secondary indication (78% of organizations support this type of IIT)
The study engaged 46 leaders from 34 bio-pharmaceutical and medical device companies through a benchmarking survey.
Topics addressed in this report include:
- IT Submission Review and Systems
- Functional Involvement
- IIT Funding
- Future Improvements
- Important Criteria for IIT Evaluation
- Key Reasons for Rejecting IIT Proposals
Download a complimentary study excerpt here: https://www.best-in-class.com/rw106.htm
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.